CD133 as a target for colon cancer

By Catalano Veronica   Di Franco Simone   Iovino Flora   Dieli Francesco   Stassi Giorgio   Todaro Matilde  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 3, 2012-03 ,pp. : 259-267

Informa Healthcare

Access to resources Recommend Favorite

Development of Effective Cancer Vaccine Using Targeting System of Antigen Protein to APCs

By Kurosaki Tomoaki   Kitahara Takashi   Nakamura Tadahiro   Nishida Koyo   Fumoto Shintaro   Kodama Yukinobu   Nakagawa Hiroo   Higuchi Norihide   Sasaki Hitoshi  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 483-489

Springer Publishing Company

Access to resources Recommend Favorite

Targeting of Jak/STAT Pathway in Antigen Presenting Cells in Cancer

By  

Current Cancer Drug Targets, Vol. 7, Iss. 1, 2007-02 ,pp. : 71-77

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art

By  

Current Drug Targets, Vol. 17, Iss. 9, 2016-07 ,pp. : 1072-1082

Bentham Science Publishers

Access to resources Recommend Favorite

Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma

By Hou Ya-Chin   Chao Ying-Jui   Tung Hui-Ling   Wang Hao-Chen   Shan Yan-Shen  

Cancer, Vol. 120, Iss. 17, 2014-09 ,pp. : 2766-2777

Blackwell Publishing

Access to resources Recommend Favorite